Heterogeneous expression of toll-like receptors in lymphatic endothelial cells derived from different tissues

Immunology and Cell Biology

Volumn 89, Issue 3, 2011, Pages 475-481

  Garrafa, Emirena ^a,b   Imberti, Luisa ^b   Tiberio, Guido ^a   Prandini, Alberto ^a   Giulini, Stefano Maria ^a   Caimi, Luigi ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Laboratory of Biotechnology   (Italy)

Author keywords

chemokines; cytokines; lymphatic endothelial cells; NF B; toll like receptor

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; THYMUS;

CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; NF-KAPPA B; TOLL-LIKE RECEPTORS;

EID: 79952815133     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.111     Document Type: Article

References (45)

1. Ryan TJ. Mechanical resilience of skin: a function of blood supply and lymphatic drainage. Clin Dermatol 1995; 13: 429-432. (Pubitemid 26073912)
2. Medzhitov R. Toll-like receptors and innateimmunity. Nat Rev Immunol 2001; 1: 135-145.
3. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-137. (Pubitemid 43135878)
4. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511. (Pubitemid 38931765)
5. Zhou H, Gu J, Lamont SJ, Gu X. Evolutionary analysis for functional divergence of the toll-like receptor gene family and altered functional constraints. J Mol Evol 2007; 65: 119-123. (Pubitemid 47383772)
6. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285: 732-736.
7. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165: 5392-5396.
8. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738. (Pubitemid 33009951)
9. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopoly-saccharides. J Immunol 2000; 165: 5780-5787.
10. Hayashi F, Smith KD, Ozinsky A, Hawn HR, Yi EC, Goodlett DR et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-1103. (Pubitemid 32391041)
11. Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, Haswell LE et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003; 424: 324-328. (Pubitemid 36899375)
12. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-1529. (Pubitemid 38314424)
13. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745. (Pubitemid 32015992)
14. Sandor F, Buc M. Toll-like receptors. II. Distribution and pathways involved in TLR signalling. Folia Biol 2005; 51: 188-197. (Pubitemid 43056599)
15. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999; 18: 6867-6874.
16. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866.
17. Lee H, Lin CI, Liao JJ, Lee YW, Yang HY, Lee CY et al. Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi-and NF-kappaB-dependent mechanism. Am J Physiol Cell Physiol 2004; 287: 1657-1666.
18. Imaizumi T, Yoshida H, Nishi N, Sashinami H, Nakamura T, Hirashima M et al. Double-stranded RNA induces galectin-9 in vascular endothelial cells: involvement of TLR3, PI3K, and IRF3 pathway Glycobiology 2007; 17: 12-15.
19. Triantafilou M, Gamper FG, Lepper PM, Mouratis MA, Schumann C, Harokopakis E et al. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol 2007; 9: 2030-2039. (Pubitemid 47087093)
20. Nakamura N, Yoshida M, Umeda M, Huang Y, Kitajima S, Inoue Y. Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis 2008; 196: 59-67.
21. Wang HL, Akinci IO, Baker CM, Urich D, Bellmeyer A, Jain M et al. The intrinsic apoptotic pathway is required for lipopolysaccharide-induced lung endothelial cell death. J Immunol 2007; 179: 1834-1841.
22. Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol 2008; 180: 3399-3405.
23. Garrafa E, Alessandri G, Benetti A, Turetta D, Corradi A, Cantoni AM et al. Isolation and characterization of lymphatic microvascular endothelial cells from human tonsils. J Cell Physiol 2006; 207: 107-113.
24. Garrafa E, Trainini L, Benetti A, Saba E, Fezzardi L, Lorusso B et al. Isolation, purification, and heterogeneity of human lymphatic endothelial cells from different tissues. Lymphology 2005; 38: 159-166. (Pubitemid 43165433)
25. Horng T, Medzhitov R. Drosophila MyD88 is an adapter in the Toll signaling pathway. Proc Natl Acad Sci USA 2001; 98: 12654-12658. (Pubitemid 33020001)
26. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates myco-bacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96: 14459-14463. (Pubitemid 30000672)
27. Qureshi S, Lariviere L, Leveque G, Clermont S, Moore K, Gros P et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (TLR4). J Exp Med 1999; 189: 615-625. (Pubitemid 29193362)
28. Nakao Y, Funami K, Kikkawa S, Taniguchi M, Nishiguchi M, Fukumori Y et al. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J Immunol 2005; 174: 1566-1573.
29. Kawai T, Akira S. TLR signaling. Cell Death Differ 2006; 13: 816-825.
30. Gewirtz A, Simon P, Schmitt C, Taylor L, Hagedorn C, O'Brien A et al. Salmonella typhimurium translocatesflagellin across intestinal epithelia, inducing a proinflamma-tory response. J Clin Invest 2001; 107: 99-109. (Pubitemid 32047419)
31. Means T, Hayashi F, Smith K, Aderem A, Luster A. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 2003; 170: 5165-5175. (Pubitemid 36554749)
32. McDermott P, Ciacci-Woolwine F, Snipes J, Mizel S. High-affinity interaction between Gram-negative flagellin and a cell surface polypeptide results in human monocyte activation. Infect Immun 2000; 68: 5525-5529.
33. Gewirtz A, Navas T, Lyons S, Godowski P, Madara J. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167: 1882-1885. (Pubitemid 32747491)
34. Maaser C, Heidemann J, von Eiff C, Lugering A, Spahn TW, Binion DG et al. Human intestinal microvascular endothelial cellsexpressToll-like receptor 5: a binding partner for bacterial flagellin. J Immunol 2004; 172: 5056-5062. (Pubitemid 38456433)
35. Merlo A, Calcaterra C, Mènard S, Balsari A. Cross-talkbetweentoll- likereceptors5and 9 on activation of human immune responses. J Leukoc Biol 2007; 82: 509-518. (Pubitemid 47367141)
36. Muzio M, Mantovani A. Toll-like receptors (TLRs) signalling and expression pattern. J Endotoxin Res 2001; 7: 297-300. (Pubitemid 33041068)
37. Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008; 19: 41-52. Review.
38. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 273-279. (Pubitemid 40873111)
39. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008; 99: 1501-1506.
40. Schuett H, Luchtefeld M, Grothusen C, Grote K, Schieffer B. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 2009; 102: 215-222.
41. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29: 313-326.
42. Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci 2005; 108: 205-213. (Pubitemid 40343567)
43. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008; 28: 1950-1959. Review.
44. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531-4537. (Pubitemid 34441357)
45. Witte MH, Jones K, Wilting J, Dictor M, Selg M, McHale N et al. Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Metastasis Rev 2006; 25: 159-184. (Pubitemid 43886395)